C12N 2770/32652
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2770/32652 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 3
- Assignees
- 4
- Inventors
- 8
- Latest grant
- 27 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Process for enterovirus purification and inactivation and vaccine compositions obtained thereof27 Feb 2024US 11,911,457 B2Bharat Biotech International Limited
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- Recombinant enteroviruses and uses thereof27 Jul 2023US 2023/0233669 A1Aleph Therapeutics, Inc.
- A process for enterovirus purification and inactivation and vaccine compositions obtained thereof3 Dec 2020US 2020/0376110 A1Bharat Biotech International Limited
- Methods and compositions related to increased viral production9 Jan 2020US 2020/0010830 A1University of Georgia Research Foundation, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.